Product Name:6-hydroxy-2-azabicyclo[2.2.2]octane hydrochloride

IUPAC Name:2-azabicyclo[2.2.2]octan-6-ol hydrochloride

CAS:128573-76-2
Molecular Formula:C7H14ClNO
Purity:97%
Catalog Number:CM108528
Molecular Weight:163.65

Packing Unit Available Stock Price($) Quantity
CM108528-100mg in stock ǜƎƎ
CM108528-250mg in stock ƎțƎ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:128573-76-2
Molecular Formula:C7H14ClNO
Melting Point:-
Smiles Code:OC1CC2CNC1CC2.[H]Cl
Density:
Catalog Number:CM108528
Molecular Weight:163.65
Boiling Point:
MDL No:
Storage:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Bridged Compounds
Bridged ring compound refers to any two rings in the compound, which share two non-directly connected carbon atoms, and are classified into bicyclic hydrocarbons, tricyclic hydrocarbons, tetracyclic hydrocarbons, etc. Carbon atoms used in two or more rings are bridgehead carbon atoms, and the bond connecting the bridgehead carbon atoms is called a bridge. Bridged ring compounds are a class of organic compounds that are widely present in nature and usually have important physiological activities, such as the famous anticancer drug paclitaxel and antimalarial drug artemisinin.
bridged compounds,bridged bicyclic compounds
Buy low price, high quality bridged compounds and bridged bicyclic compounds,choose our products,Chemenu is the leading factory & company. Warmly welcome new and old customers to visit and patronize!

Column Infos

Product Other Information

Product Overview 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride, also known as 6-OHDA, is a chemical compound that is widely used in scientific research to study the nervous system. This compound is a potent neurotoxin that selectively destroys dopaminergic neurons, making it a valuable tool for investigating the mechanisms underlying Parkinson's disease and other neurological disorders.
Synthesis Method The synthesis of 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride involves the oxidation of dopamine using hydrogen peroxide and iron salts. The resulting product is then purified and converted into its hydrochloride salt form. This synthesis method allows for the production of high-purity 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride that is suitable for use in scientific research.
Chemical Properties 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride is relatively easy to synthesize and can be produced in high-purity form for use in scientific research. This compound is highly toxic and can be dangerous to handle, requiring strict safety protocols to be followed.
Synthesis and Application 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride is commonly used in scientific research to study the nervous system and its functions. This compound is particularly useful in investigating the mechanisms underlying Parkinson's disease, as it selectively destroys dopaminergic neurons in the brain. This allows researchers to study the effects of dopamine depletion on the nervous system and develop new treatments for Parkinson's disease.
Future Directions One area of interest is the development of new treatments for Parkinson's disease that target the mechanisms underlying dopamine depletion. Additionally, researchers may investigate the use of 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride in studying other neurological disorders, such as Alzheimer's disease and Huntington's disease. Finally, further research may be conducted to better understand the biochemical and physiological effects of 6-Hydroxy-2-azabicyclo[2.2.2]octane hydrochloride on the nervous system, providing valuable insights into the mechanisms underlying neurological disorders.